Overview

To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata

Status:
COMPLETED

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

Alopecia areata (AA) is an autoimmune condition characterized by non-scarring hair loss, ranging from minor patches to complete baldness. Given the variable effectiveness of existing treatments, this study aimed to compare the efficacy of weekly Azathioprine pulse (WAP) therapy against Betamethasone oral mini-pulse (BOMP) therapy in managing moderate to severe AA.

Phase:

PHASE2

Details

Lead Sponsor:

Sheikh Zayed Medical College

Treatments:

Azathioprine
Betamethasone